Ken Robbins
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Oncology 4
- Lung Cancer Research Studies 2
- Pancreatic and Hepatic Oncology Research 1
- Cancer Treatment and Pharmacology 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Robert C.G. Martin (7 shared papers)Dana Tomalty (5 shared papers)Cliff Tatum (6 shared papers)Radek Pádr (2 shared papers)Miloslav Roček (2 shared papers)Ryan O’Hara (2 shared papers)Petar Bošnjaković (1 shared paper)Ricardo García Mónaco (1 shared paper)
- Journals
- Journal of Oncology (3 papers)Breast Cancer Research and Treatment (1 paper)Annals of Surgical Oncology (1 paper)HPB (1 paper)World Journal of Surgical Oncology (1 paper)
- Partner nations
- United StatesCzechiaArgentina
In The Last Decade
Ken Robbins
8 papers receiving 367 citations
Peers
Comparison fields: 5 of 23
- Hepatology 300
- Oncology 149
- Pulmonary and Respiratory Medicine 105
- Surgery 59
- Biotechnology 9
Countries citing papers authored by Ken Robbins
This map shows the geographic impact of Ken Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Robbins more than expected).
Fields of papers citing papers by Ken Robbins
This network shows the impact of papers produced by Ken Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Robbins. The network helps show where Ken Robbins may publish in the future.
Co-authors
The 11 scholars most cited alongside Ken Robbins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 151 | |
| 2 | 2009 | 80 | |
| 3 | 2009 | 65 | |
| 4 | 2010 | 37 | |
| 5 | 2011 | 26 | |
| 6 | 2012 | 10 | |
| 7 | 2012 | 1 | |
| 8 | Building a house | 1984 | 1 |
About Ken Robbins
Ken Robbins is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Infectious Diseases, having authored 8 papers that have together received 371 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Research Studies (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Lung Cancer Treatments and Mutations (1 paper), Renal cell carcinoma treatment (1 paper), Cancer Treatment and Pharmacology (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Hepatology (300 citations), Oncology (149 citations), Pulmonary and Respiratory Medicine (105 citations), Surgery (59 citations) and Biotechnology (9 citations). Ken Robbins has collaborated with scholars based in United States, Czechia and Argentina. Frequent co-authors include Robert C.G. Martin, Dana Tomalty, Cliff Tatum, Radek Pádr, Miloslav Roček, Ryan O’Hara, Petar Bošnjaković, Ricardo García Mónaco, Matthew Bower and Tomáš Andrašina. Their work appears in journals such as Journal of Oncology, Breast Cancer Research and Treatment, Annals of Surgical Oncology, HPB and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.